302 related articles for article (PubMed ID: 19111634)
21. Structural and kinetic analysis of Schistosoma mansoni Adenylosuccinate Lyase (SmADSL).
Romanello L; Serrão VHB; Torini JR; Bird LE; Nettleship JE; Rada H; Reddivari Y; Owens RJ; DeMarco R; Brandão-Neto J; Pereira HD
Mol Biochem Parasitol; 2017 Jun; 214():27-35. PubMed ID: 28347672
[TBL] [Abstract][Full Text] [Related]
22. Three subunits contribute amino acids to the active site of tetrameric adenylosuccinate lyase: Lys268 and Glu275 are required.
Brosius JL; Colman RF
Biochemistry; 2002 Feb; 41(7):2217-26. PubMed ID: 11841213
[TBL] [Abstract][Full Text] [Related]
23. A key role in catalysis for His89 of adenylosuccinate lyase of Bacillus subtilis.
Brosius JL; Colman RF
Biochemistry; 2000 Nov; 39(44):13336-43. PubMed ID: 11063569
[TBL] [Abstract][Full Text] [Related]
24. Arg40 is critical for stability and activity of Adenylosuccinate lyase; a purine salvage enzyme from Leishmania donovani.
Mochi JA; Jani J; Tak K; Lodhi KK; Pananghat G; Pappachan A
Arch Biochem Biophys; 2024 Jul; 757():110040. PubMed ID: 38750922
[TBL] [Abstract][Full Text] [Related]
25. The structure of adenylosuccinate lyase, an enzyme with dual activity in the de novo purine biosynthetic pathway.
Toth EA; Yeates TO
Structure; 2000 Feb; 8(2):163-74. PubMed ID: 10673438
[TBL] [Abstract][Full Text] [Related]
26. Biochemical role of the Cryptococcus neoformans ADE2 protein in fungal de novo purine biosynthesis.
Firestine SM; Misialek S; Toffaletti DL; Klem TJ; Perfect JR; Davisson VJ
Arch Biochem Biophys; 1998 Mar; 351(1):123-34. PubMed ID: 9500840
[TBL] [Abstract][Full Text] [Related]
27. Adenylosuccinate lyase deficiency: from the clinics to molecular biology.
Marie S; Race V; Vincent MF; Van den Berghe G
Adv Exp Med Biol; 2000; 486():79-82. PubMed ID: 11783532
[No Abstract] [Full Text] [Related]
28. Human malaria parasite orotate phosphoribosyltransferase: functional expression, characterization of kinetic reaction mechanism and inhibition profile.
Krungkrai SR; Aoki S; Palacpac NM; Sato D; Mitamura T; Krungkrai J; Horii T
Mol Biochem Parasitol; 2004 Apr; 134(2):245-55. PubMed ID: 15003844
[TBL] [Abstract][Full Text] [Related]
29. Understanding the structural insights of enzymatic conformations for adenylosuccinate lyase receptor in malarial parasite
Al-Malki ES
J Recept Signal Transduct Res; 2021 Dec; 41(6):566-573. PubMed ID: 33073638
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of adenylosuccinate lyase by L-alanosyl-5-aminoimidazole-4-carboxylic acid ribonucleotide (alanosyl-AICOR).
Casey PJ; Lowenstein JM
Biochem Pharmacol; 1987 Mar; 36(5):705-9. PubMed ID: 3827951
[TBL] [Abstract][Full Text] [Related]
31. Clinical, biochemical and molecular genetic correlations in adenylosuccinate lyase deficiency.
Race V; Marie S; Vincent MF; Van den Berghe G
Hum Mol Genet; 2000 Sep; 9(14):2159-65. PubMed ID: 10958654
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the cDNA and the gene encoding murine adenylosuccinate lyase.
Wong LJ; O'Brien WE
Genomics; 1995 Jul; 28(2):341-3. PubMed ID: 8530047
[TBL] [Abstract][Full Text] [Related]
33. Mapping of the bovine genes of the de novo AMP synthesis pathway.
Bønsdorff T; Gautier M; Farstad W; Rønningen K; Lingaas F; Olsaker I
Anim Genet; 2004 Dec; 35(6):438-44. PubMed ID: 15566465
[TBL] [Abstract][Full Text] [Related]
34. Radiochemical assay of adenylosuccinase: demonstration of parallel loss of activity toward both adenylosuccinate and succinylaminoimidazole carboxamide ribotide in liver of patients with the enzyme defect.
Van den Bergh F; Vincent MF; Jaeken J; Van den Berghe G
Anal Biochem; 1991 Mar; 193(2):287-91. PubMed ID: 1872474
[TBL] [Abstract][Full Text] [Related]
35. Human AICAR transformylase: role of the 4-carboxamide of AICAR in binding and catalysis.
Wall M; Shim JH; Benkovic SJ
Biochemistry; 2000 Sep; 39(37):11303-11. PubMed ID: 10985775
[TBL] [Abstract][Full Text] [Related]
36. Disruption of the purine nucleotide cycle by inhibition of adenylosuccinate lyase produces skeletal muscle dysfunction.
Swain JL; Hines JJ; Sabina RL; Harbury OL; Holmes EW
J Clin Invest; 1984 Oct; 74(4):1422-7. PubMed ID: 6480832
[TBL] [Abstract][Full Text] [Related]
37. Role of W181 in modulating kinetic properties of Plasmodium falciparum hypoxanthine guanine xanthine phosphoribosyltransferase.
Roy S; Karmakar T; Nagappa LK; Prahlada Rao VS; Balasubramanian S; Balaram H
Proteins; 2016 Nov; 84(11):1658-1669. PubMed ID: 27479359
[TBL] [Abstract][Full Text] [Related]
38. Plasmodium falciparum glyoxalase II: Theorell-Chance product inhibition patterns, rate-limiting substrate binding via Arg(257)/Lys(260), and unmasking of acid-base catalysis.
Urscher M; Deponte M
Biol Chem; 2009 Nov; 390(11):1171-83. PubMed ID: 19663684
[TBL] [Abstract][Full Text] [Related]
39. Molecular characterization, heterologous expression and kinetic analysis of recombinant Plasmodium falciparum thymidylate kinase.
Kandeel M; Kitade Y
J Biochem; 2008 Aug; 144(2):245-50. PubMed ID: 18477629
[TBL] [Abstract][Full Text] [Related]
40. Aspartase/fumarase superfamily: a common catalytic strategy involving general base-catalyzed formation of a highly stabilized aci-carboxylate intermediate.
Puthan Veetil V; Fibriansah G; Raj H; Thunnissen AM; Poelarends GJ
Biochemistry; 2012 May; 51(21):4237-43. PubMed ID: 22551392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
